Search results for "Amphotericin"

showing 10 items of 68 documents

Visceral leishmaniasis in a patient with Down syndrome

2006

Pathologymedicine.medical_specialtyDown syndromeAntiprotozoal AgentsMEDLINEAntibodies ProtozoanAneuploidyAmphotericin BAnimalsHumansvisceral leishmaniasisMedicineProtozoal diseaseLeishmaniabusiness.industryInfantLeishmaniasismedicine.diseasePancytopeniaDermatologyVisceral leishmaniasisSplenomegalyPediatrics Perinatology and Child HealthLeishmaniasis VisceralDown SyndromebusinessTrisomyHepatomegalyEuropean Journal of Pediatrics
researchProduct

In vitro susceptibility of e.faecalis and c.albicans isolates from apical periodontitis to common antimicrobial agents, antibiotics and antifungal me…

2012

The aim of this study was to evaluate in vitro antimicrobial activity of 4 antibiotic agents (for E.faecalis) and 4 antifungal agents (for C.albicans) by agar dilution method. Additionally, modified strip diffusion method was used for detection of in vitro antimicrobial activities of 5% NaOCl, 2.5% NaOCl, 17% EDTA and 2% CHX and agar diffusion method for detection of in vitro susceptibilities of three intracanal medicaments for 18 E.faecalis and 18 C.albicans isolates from primary and secondary root canal infection. Isolates were recovered from 231 endodontic samples of patients, with the need of root canal treatment and retreatment. All tested E.faecalis isolates showed resistance to antib…

Pathologymedicine.medical_specialtyE.faecalismedicine.drug_classRoot canalmedicine.medical_treatmentAntibioticsOdontologíaAntifungalC.albicansMicrobiologyClinical and Experimental DentistryAmphotericin BmedicineAgar diffusion testGeneral DentistrySalinebusiness.industryResearchAntibiotic:CIENCIAS MÉDICAS [UNESCO]AntimicrobialCiencias de la saludmedicine.anatomical_structureUNESCO::CIENCIAS MÉDICASKetoconazoleAntimicrobialbusinessFluconazolemedicine.drug
researchProduct

Amphotericin B Penetrates into the Central Nervous System through Focal Disruption of the Blood-Brain Barrier in Experimental Hematogenous Candida Me…

2019

Hematogenous Candida meningoencephalitis (HCME) is a life-threatening complication of neonates and immunocompromised children. Amphotericin B (AmB) shows poor permeability and low cerebrospinal fluid (CSF) concentrations, but is effective in treatment of HCME. In order to better understand the mechanism of CNS penetration of AmB, we hypothesized that AmB may achieve focally higher concentrations in infected CNS lesions. An in vitro BBB model was serially infected with C. albicans. Liposomal AmB (LAMB) or deoxycholate AmB (DAMB) at 5 μg/ml were then provided, vascular and CNS compartments were sampled 4h later. For in vivo correlation, rabbits with experimental HCME received a single dose of…

Pathologymedicine.medical_specialtyanimal diseasesCentral nervous systemBlood–brain barrier03 medical and health scienceschemistry.chemical_compound0302 clinical medicineCerebrospinal fluidIn vivoAmphotericin BmedicinePharmacology (medical)030212 general & internal medicineEvans BluePharmacology0303 health sciences030306 microbiologybusiness.industryMeningoencephalitismedicine.diseaseInfectious Diseasesmedicine.anatomical_structurechemistryComplicationbusinessmedicine.drugAntimicrobial Agents and Chemotherapy
researchProduct

Pulmonary aspergilloma in a patient with AIDS.

1995

Aspergillus infections are rare in the course of AIDS. They mostly occur as invasive destructive disease in patients with severe CD4 cell depletion. An unusual case of a homosexual AIDS patient who developed a pulmonary aspergilloma is presented.

Pulmonary and Respiratory MedicineMalemedicine.medical_specialtyPathologyAIDS-Related Opportunistic InfectionsAspergillosisAcquired immunodeficiency syndrome (AIDS)Amphotericin BmedicineAspergillosisHumansskin and connective tissue diseasesMycosisLungAIDS-Related Opportunistic InfectionsLung Diseases Fungalbusiness.industryAspergillus fumigatusRespiratory diseaseMiddle Agedmedicine.diseaseDermatologymedicine.anatomical_structureItraconazoleComplicationbusinessAspergillomaResearch Article
researchProduct

Anidulafungin in combination with amphotericin B against Aspergillus fumigatus.

2009

ABSTRACT We investigated the effects of anidulafungin alone and in combination with amphotericin B against Aspergillus fumigatus . Indifference was the only type of interaction observed in vitro. Anidulafungin at 1 and 5 mg/kg of body weight/day, amphotericin B at 1 mg/kg/day, and combination therapy prolonged the survival of mice with invasive aspergillosis. Anidulafungin at 5 mg/kg/day, alone and in combination with amphotericin B, reduced the kidney fungal burden. Overall, the combination was not superior to the most active single drug.

Settore MED/07 - Microbiologia E Microbiologia ClinicaAntifungal AgentsCombination therapymedicine.drug_classAntibioticsMicrobial Sensitivity TestsPharmacologyAspergillosisAnidulafunginKidneyAspergillus fumigatusMicrobiologyEchinocandinsMicePharmacotherapyAmphotericin BAmphotericin BmedicineAnimalsAspergillosisPharmacology (medical)Experimental TherapeuticsPharmacologyAspergillusbiologyAspergillus fumigatusaspergillus anidulafungin amphotericin BBrainbiology.organism_classificationmedicine.diseasebacterial infections and mycosesInfectious DiseasesAnidulafunginDrug Therapy Combinationmedicine.drugAntimicrobial agents and chemotherapy
researchProduct

Novel aspect of amphotericin B action: accumulation in human monocytes potentiates killing of phagocytosed Candida albicans.

1994

The influence of low doses of amphotericin B on the capacity of human monocytes to kill Candida albicans was investigated. Killing rates were quantified by a novel flow cytometric assay and were found to be 37% +/- 3% (standard error of the mean) after 3 h. Preincubation of monocytes for 6 to 20 h with low concentrations of amphotericin B (0.2 microgram/ml) resulted in a markedly augmented fungicidal capacity. Enhancement of killing was 80% +/- 11% (standard error of the mean) over that by the controls. This effect did not appear to be due to amphotericin B-dependent monocyte activation; the respiratory burst and expression of human leukocyte antigen-DR were unaltered, and no stimulation of…

Staphylococcus aureusPhagocytosisBiologyIn Vitro Techniquesmedicine.disease_causeMonocytesMicrobiologyPhagocytosisAmphotericin BAmphotericin BCandida albicansMacrophages AlveolarmedicineHumansPharmacology (medical)Candida albicansRespiratory BurstPharmacologyMonocyteHLA-DR Antigensbiology.organism_classificationCorpus albicansStimulation ChemicalRespiratory burstInfectious Diseasesmedicine.anatomical_structureStaphylococcus aureusIntracellularmedicine.drugInterleukin-1Research ArticleAntimicrobial agents and chemotherapy
researchProduct

Diagnosis and antimicrobial therapy of pulmonary infiltrates in febrile neutropenic patients

2003

Patients with severe neutropenia lasting for more than 10 days, who develop fever and pulmonary infiltrates, are at high risk of treatment failure and infection-related death, under conventional broad-spectrum antibiotics. Early supplementation by a systemic antifungal therapy active against Aspergillus spp. has been shown to markedly improve their clinical outcome. Prognosis is significantly influenced by early identification of lung infiltrates by means of high-resolution thoracic computed tomography. Non-culture based diagnostic procedures using a highly sensitive Sandwich ELISA assay to detect circulating galactomannan, or PCR techniques to amplify circulating fungal DNA, may facilitate…

Voriconazolemedicine.medical_specialtyPathologymedicine.diagnostic_testbusiness.industryRespiratory diseaseHematologyGeneral MedicineNeutropeniamedicine.diseaseAspergillosisGastroenterologyBronchoalveolar lavageAmphotericin B deoxycholateInternal medicinemedicinebusinessFebrile neutropeniaMycosismedicine.drugAnnals of Hematology
researchProduct

La somministrazione di amphotericina B per via endoarteriosa rappresenta una valida e sicura terapia della mucormicosi

2003

amphotericina B terapia mucormicosi
researchProduct

Combination therapy in a model of pulmonary aspergillosis

2009

Summary. The current treatment for pulmonary aspergillosis, amphotericin B, is toxic and not always effective. This study was done to evaluate combinations of amphotericin B with other agents in an animal model of pulmonary aspergillosis. Sprague-Dawley rats were treated with cortisone acetate, infected intratracheally with 106 spores of Aspergillus fumigatus, and followed daily for survival. Mortality among controls started on day 2, and it was 80% by day seven, whereas therapy with amphotericin B resulted in survival of all animals. When given alone, ketoconazole, 5-fluorocytosine and rifampin did not improve survival. The combination of ketoconazole with amphotericin B resulted in comple…

biologyCombination therapyItraconazolebusiness.industryDermatologyGeneral MedicinePharmacologybiology.organism_classificationAspergillosismedicine.diseaseAspergillus fumigatusFlucytosineInfectious DiseasesAmphotericin BImmunologymedicineKetoconazolebusinessMycosismedicine.drugMycoses
researchProduct

Investigation of fungicidal activity of 3-piperazine-bis(benzoxaborole) and its boronic acid analogue

2014

3-Piperazine-bis(benzoxaborole) and its bis(phenylboronic acid) analogue were investigated in terms of their fungicidal activity. The study was carried out against five filamentous fungi: Aspergillus terreus, Fusarium dimerum, Fusarium solani, Penicillium ochrochloron and Aspergillus niger. 3-Piperazine-bis(benzoxaborole) revealed higher inhibitory activity towards the examined strains than standard antibiotic (amphotericin B), whereas bis(phenylboronic acid) proved to be inactive. The study unequivocally showed that the presence of the heterocyclic benzoxaborole system is essential for antifungal action of the examined compounds. Copyright © 2014 John Wiley & Sons, Ltd.

biologyStereochemistryAspergillus nigerfood and beveragesGeneral Chemistrybiology.organism_classificationInorganic Chemistrychemistry.chemical_compoundPiperazinechemistryAmphotericin BmedicineAspergillus terreusPhenylboronic acidFusarium solaniBoronic acidmedicine.drugPenicillium ochrochloronApplied Organometallic Chemistry
researchProduct